妊娠期类风湿关节炎缓解机制的系统综述
该系统综述检索Medline、PubMed和EMBASE,最终纳入37篇原始研究,评估妊娠期类风湿关节炎(RA)缓解的潜在机制。免疫球蛋白糖基化(尤其是半乳糖化水平升高)与疾病活动度降低相关的研究最多(9篇),但各研究异质性大且结果偶有矛盾。结论认为妊娠诱导RA缓解的确切原因仍未确定。
要点
- 免疫球蛋白半乳糖化水平升高与妊娠期RA疾病活动度降低相关。
- 纳入37篇原始研究,涉及糖基化、细胞因子、HLA不相容等多种机制。
- 各研究人群规模、方法和对照使用差异大,结果异质性明显。
核心结论
- 妊娠诱导RA缓解的确切原因仍未确定,尽管已有大量研究探索。
- 尚不明确妊娠期各种暂时性变化中哪一种可能启动下游抗炎免疫机制。
研究设计与样本
- 按照PRISMA指南进行的系统综述,检索Medline、PubMed和EMBASE数据库。
- 最终纳入37篇原始研究文章,由两名独立评审者筛选文献并提取数据。
主要发现
- 免疫球蛋白糖基化相关文献最多(9篇),证据显示免疫球蛋白半乳糖化水平升高与妊娠期RA疾病活动度降低相关。
- 其他研究涉及细胞因子变化(5篇)、HLA不相容(5篇)、外周血单个核细胞基因表达变化(5篇)、皮质类固醇变化(4篇)。
- 另有妊娠相关α2-糖蛋白(3篇)、RF/ACPA变化(2篇),以及微嵌合体、γδT细胞、调节性T细胞和甘露糖结合凝集素各1篇。
- 各研究结果异质性大,偶尔相互矛盾,研究在人群规模、方法学、对照使用和疾病活动度评估方面差异很大。
临床怎么用
- 临床应认识到妊娠期RA缓解机制尚未明确,不能基于单一机制解释或预测患者病情变化。
- 免疫球蛋白半乳糖化水平与疾病活动度降低的关联可作为未来机制研究的参考方向。
局限性
- 纳入研究在人群规模、方法学、对照使用和疾病活动度评估方面差异很大。
- 各研究结果异质性大且偶尔相互矛盾,限制了机制结论的可靠性。
- 非英语文献和直接不相关的研究被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The phenomenon of pregnancy-induced remission of rheumatoid arthritis (RA) was first reported by Philip Hench in 1938. Despite extensive efforts, the underlying scientific basis has remained elusive. A number of different potential mechanisms have been investigated. We have undertaken a systematic review of the available peer-reviewed articles involving pregnant patients with RA in order to establish the depth of current scientific understanding of this important topic. METHODS: This review was conducted according to guidelines of preferred reporting items for systematic reviews and meta-analyses. Studies were identified by a thorough search of multiple databases including Medline, PubMed and EMBASE. Search terms used were different combinations of the keywords: rheumatoid arthritis, inflammatory arthritis, pregnancy, mechanisms, disease activity, relapse and remission. Non-English language articles and studies that were not directly relevant were excluded. Two independent reviewers (CR and KA) screened the retrieved articles by reading the title and abstract to identify studies that addressed potential mechanisms determining RA activity in pregnancy. Articles were further refined after reading the full text. A data extraction sheet was developed for the purpose of this review and used by the independent reviewers. RESULTS: After exclusion of irrelevant, duplicate and foreign language articles, a final total of 37 original articles were identified. The largest body of literature concerned glycosylation of immunoglobulins, with 9 published articles. There is evidence of an association between increasing levels of galactosylation of immunoglobulins and reduced RA disease activity in pregnancy. Other identified articles comprised 5 on cytokine changes in pregnancy, 5 on human leucocyte antigen (HLA) incompatibility, 5 on changes in peripheral blood mononuclear cell (PBMC) gene expression; 4 on changes in corticosteroids; 3 on pregnancy associated α2-glycoprotein; 2 on changes in rheumatoid factor (RF)/anti-citrullinated protein antibody (ACPA); and 1 each on microchimerism, gamma delta T cells, regulatory T cells, and mannose-binding lectin. The results of these studies were heterogenous and occasionally conflicting. Selected studies varied greatly in terms of population size, methodology and use of controls and disease activity assessments. CONCLUSION: This systematic review has found that the cause of the pregnancy-induced amelioration of RA remains to be determined, despite extensive efforts. It is unclear which of the various transitory changes in pregnancy may be responsible for initiating downstream anti-inflammatory immunological mechanisms. We discuss limitations of the current literature and suggest areas for future study.
引用
- Raine C, Austin K, Giles I, et al. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. Semin Arthritis Rheum. 2020. PMID: 32224046. doi:10.1016/j.semarthrit.2020.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。